Mjali, A. et al. 2022. Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. Asian Pacific Journal of Cancer Care. 7, 2 (Jun. 2022), 267–272. DOI:https://doi.org/10.31557/apjcc.2022.7.2.267-272.